INTERNATIONAL TRADE LAW
Cosmetic, Drug, or Both? FDA Product Classification

Whether the FDA treats your product as a cosmetic, a drug, or both comes down to its intended use — not its ingredients, its packaging, or what you call it. That single classification decision drives everything that follows: whether you need FDA approval before selling, which manufacturing and labeling rules apply, and how much your compliance burden costs. Many products that look like ordinary cosmetics are legally drugs, and getting the call wrong invites warning letters, import refusals, and seizures.
Both categories are regulated under the Federal Food, Drug, and Cosmetic Act (FD&C Act), but they sit on very different tracks. Here is how the line is drawn.
How the FDA defines a cosmetic vs. a drug
The FD&C Act defines each category by intended use.
| Cosmetic — FD&C Act § 201(i) | Drug — FD&C Act § 201(g) | |
|---|---|---|
| Intended use | Cleansing, beautifying, promoting attractiveness, or altering appearance | Diagnosing, curing, mitigating, treating, or preventing disease — or affecting the structure or function of the body |
| Examples | Skin cream, makeup, perfume, shampoo, nail polish | Acne treatment, antiperspirant, sunscreen, fluoride toothpaste |
| Premarket approval? | No FDA approval required (color additives are an exception) | Yes — a new drug application, or compliance with an OTC drug monograph |
A cosmetic enhances appearance. A drug acts on the body to treat a condition or change how the body works. The same jar of lotion can be one or the other depending on what the maker claims it does.
It’s the intended use, not the ingredient
The FDA infers intended use from claims, labeling, consumer expectations, and even ingredients known to have a therapeutic effect. A few examples make the point:
- A moisturizer is a cosmetic. Add a claim that it “reduces wrinkles by stimulating collagen” — a structure/function claim — and it becomes a drug.
- A shampoo is a cosmetic. Market it to “treat dandruff,” and it is also a drug.
- A lip balm is a cosmetic. Add “SPF 30” and a sun-protection claim, and it is also a drug.
You cannot escape drug regulation by burying a disease claim in marketing copy, a website, or social media. The FDA looks at the whole context of how the product is presented to the consumer.
Products that are both a cosmetic and a drug
Some products meet both definitions at once because they have more than one intended use. These “cosmetic-drug” products must comply with the requirements for both categories. Common examples:
| Product | Cosmetic use | Drug use |
|---|---|---|
| Anti-dandruff shampoo | Cleanses hair | Treats dandruff |
| Fluoride toothpaste | Cleans teeth | Prevents cavities |
| Antiperspirant-deodorant | Reduces odor | Reduces perspiration (a body function) |
| Moisturizer or makeup with SPF | Beautifies skin | Protects against sun-induced damage |
For these products, “comply with both” usually means meeting the applicable over-the-counter (OTC) drug monograph — the FDA’s pre-set formulation and labeling standard for a class of nonprescription drugs — and also following cosmetic labeling and safety rules.
“Cosmeceutical” has no legal meaning
Marketers love the word “cosmeceutical” to suggest a product is a cosmetic with drug-like benefits. The FD&C Act does not recognize that category. Under the law a product is a cosmetic, a drug, or both — there is no in-between. Calling a product a cosmeceutical changes nothing about how the FDA regulates it; the intended-use analysis still controls.
What the classification means for your obligations
The category you land in sets the rules of the road.
If the product is a cosmetic, there is no FDA premarket approval (except for color additives), but it must not be adulterated or misbranded, must be properly labeled, and — since the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) — is subject to facility registration, product listing, safety substantiation, and adverse-event reporting requirements. (MoCRA’s facility registration and product listing requirements took effect after FDA exercised enforcement discretion through July 1, 2024.) For the cosmetic import process specifically, see our guides on importing cosmetics under FDA rules and how to import cosmetics.
If the product is a drug, you generally need either an approved new drug application or compliance with the relevant OTC monograph, plus drug current Good Manufacturing Practices, drug-facility registration and listing, and drug labeling (including a Drug Facts panel). That is a substantially heavier and more expensive pathway — which is exactly why the classification decision is worth getting right at the design stage.
Frequently asked questions
Is sunscreen a cosmetic or a drug? In the U.S., sunscreen is regulated as an OTC drug because it is intended to protect against sun-induced harm. Makeup or moisturizer marketed with SPF/sun-protection claims is a cosmetic-drug and must meet both sets of rules.
Does the FDA approve cosmetics before they go on sale? No. Cosmetics (other than color additives) do not need FDA premarket approval. They must still be safe, properly labeled, and — under MoCRA — backed by facility registration, product listing, and safety substantiation.
Can a product be both a cosmetic and a drug? Yes. A product with more than one intended use — like anti-dandruff shampoo or SPF moisturizer — is both, and must comply with the requirements for cosmetics and drugs simultaneously.
Will calling my product a “cosmeceutical” keep it out of drug regulation? No. The term has no legal status. If your claims or ingredients give the product a drug intended use, it is regulated as a drug regardless of the label you use.
Get your classification right before you launch or import
Reidel Law Firm helps brands and importers analyze intended-use claims, classify products correctly, and build a compliant labeling and import plan — delivered as a flat-fee import/export compliance memo with direct attorney access. Get a flat-fee import compliance memo →
For broader context, see our overview of U.S. food laws and the firm’s International Trade Law practice page.


